AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 25251432 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose intermittent (three doses of 45 mg/kg q 6 hr repeated q 1 wk)
Number of subjects: 24
Study 25251432 — intervention group
Group type: COMPARATOR
Intervention: Both low-dose continuous and high-dose intermittent
Number of subjects: 24
Study 22133661 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal ring (daily dose of 15 mcg ethinylestradiol/120 mcg etonogestrel)
Number of subjects: 55
Study 22133661 — intervention group
Group type: EXPERIMENTAL
Intervention: Short or long CAG repeats
Number of subjects: 55
Study 22133661 — intervention group
Group type: EXPERIMENTAL
Intervention: Mood of the woman
Number of subjects: 55
Study 20663495 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral contraception (OC) for 6 to 8 weeks before assisted reproduction treatment (ART)
Number of subjects: 0
Study 20663495 — intervention group
Group type: COMPARATOR
Intervention: No pre-treatment with oral contraception (OC)
Number of subjects: 0
Study 20663495 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral contraception (OC) for 6 to 8 weeks before ART
Number of subjects: 0
Study 17167265 — intervention group
Group type: EXPERIMENTAL
Intervention: TiF(4)
Number of subjects: 32
Study 17167265 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 32
Study 17167265 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-hour pellicle
Number of subjects: 32
Study 17167265 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-hour pellicle + TiF(4)
Number of subjects: 32
Study 14713317 — intervention group
Group type: EXPERIMENTAL
Intervention: Interviewer-administered CRQ
Number of subjects: 162
Study 14713317 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-administered CRQ
Number of subjects: 162
Study 14713317 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardised dyspnoea questions
Number of subjects: 162
Study 14713317 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualised dyspnoea questions
Number of subjects: 162
Study 14713317 — intervention group
Group type: COMPARATOR
Intervention: Control group (stable COPD patients without intervention)
Number of subjects: 162
Study 11673291 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrogel IOL
Number of subjects: 100
Study 11673291 — intervention group
Group type: COMPARATOR
Intervention: Acrylic IOL
Number of subjects: 100
Study 9678814 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 week co-therapy with amoxycillin (1 g b.d.) and clarithromycin (500 mg b.d.)
Number of subjects: 67
Study 9678814 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 week co-therapy with amoxycillin (1 g b.d.) and clarithromycin (500 mg b.d.)
Number of subjects: 67
Study 7735085 — intervention group
Group type: EXPERIMENTAL
Intervention: Assertive case management
Number of subjects: 0
Study 7735085 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 2591463 — intervention group
Group type: EXPERIMENTAL
Intervention: Alfuzosin 5 mg
Number of subjects: 6
Study 2591463 — intervention group
Group type: COMPARATOR
Intervention: Prazosin 1 mg
Number of subjects: 6
Study 2591463 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study 2591463 — intervention group
Group type: EXPERIMENTAL
Intervention: Alfuzosin 10 mg
Number of subjects: 6
Study 2591463 — intervention group
Group type: EXPERIMENTAL
Intervention: Alfuzosin 1 mg and 5 mg
Number of subjects: 6
Study 29564482 — intervention group
Group type: COMPARATOR
Intervention: LY2140023 (10, 40, and 160 mg)
Number of subjects: 32
Study 29564482 — intervention group
Group type: COMPARATOR
Intervention: LY2979165 (20 and 60 mg)
Number of subjects: 32
Study 27392846 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive Rehabilitation Program (IRP) starting on the second postoperative day
Number of subjects: 126
Study 27392846 — intervention group
Group type: COMPARATOR
Intervention: Standard Rehabilitation Program (SRP) starting after 3 weeks
Number of subjects: 126
Study 27392846 — intervention group
Group type: EXPERIMENTAL
Intervention: Both IRP and SRP
Number of subjects: 126
Study 26063068 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron (300 mg ferrous sulfate) + 0.40 mg folate
Number of subjects: 2371
Study 26063068 — intervention group
Group type: COMPARATOR
Intervention: Placebo + 0.40 mg folate
Number of subjects: 2371
Study 23810047 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic curd
Number of subjects: 60
Study 23810047 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic toothpaste
Number of subjects: 60
Study 23810047 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 60
Study 21903021 — intervention group
Group type: EXPERIMENTAL
Intervention: Raloxifene (60 mg/d)
Number of subjects: 33
Study 21903021 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study 18362867 — intervention group
Group type: EXPERIMENTAL
Intervention: Guanfacine
Number of subjects: 0
Study 18362867 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 16539557 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct bonding with Transbond XT
Number of subjects: 60
Study 16539557 — intervention group
Group type: EXPERIMENTAL
Intervention: Indirect bonding with Transbond XT/Sondhi Rapid Set (chemically cured)
Number of subjects: 60
Study 16539557 — intervention group
Group type: EXPERIMENTAL
Intervention: Indirect bonding with Enlight LV/Orthosolo (light cured)
Number of subjects: 60
Study 12754885 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiotensin receptor blockers (ARBs)
Number of subjects: 0
Study 12754885 — intervention group
Group type: EXPERIMENTAL
Intervention: ACE inhibitors or ARBs
Number of subjects: 0
Study 10933346 — intervention group
Group type: EXPERIMENTAL
Intervention: abciximab
Number of subjects: 0
Study 8815481 — intervention group
Group type: EXPERIMENTAL
Intervention: Amikacin once daily (group A)
Number of subjects: 50
Study 8815481 — intervention group
Group type: COMPARATOR
Intervention: Amikacin thrice daily plus carbenicillin (group B)
Number of subjects: 50
Study 1444488 — intervention group
Group type: EXPERIMENTAL
Intervention: UFT administration
Number of subjects: 182
Study 1444488 — intervention group
Group type: COMPARATOR
Intervention: FT‐E administration
Number of subjects: 182
Study 2861767 — intervention group
Group type: EXPERIMENTAL
Intervention: Terfenadine 60 mg bid
Number of subjects: 397
Study 2861767 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorpheniramine 4 mg tid
Number of subjects: 397
Study 2861767 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 397
Study 2861767 — intervention group
Group type: EXPERIMENTAL
Intervention: Terfenadine
Number of subjects: 397
Study 2861767 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorpheniramine
Number of subjects: 397
Study 31084483 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent Forum
Number of subjects: 41
Study 31084483 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent Forum II
Number of subjects: 41
Study 31084483 — intervention group
Group type: COMPARATOR
Intervention: Monthly phone calls from a mental health professional
Number of subjects: 41
Study 31084483 — intervention group
Group type: COMPARATOR
Intervention: Services as usual
Number of subjects: 41
Study 30030699 — intervention group
Group type: EXPERIMENTAL
Intervention: Hazelnut and cocoa spread (60 g)
Number of subjects: 20
Study 30030699 — intervention group
Group type: COMPARATOR
Intervention: Milk chocolate (60 g)
Number of subjects: 20
Study 26891618 — intervention group
Group type: EXPERIMENTAL
Intervention: RXU (RelyX Unicem)
Number of subjects: 34
Study 26891618 — intervention group
Group type: COMPARATOR
Intervention: RXU+E (RelyX Unicem with selective enamel etching)
Number of subjects: 34
Study 24684948 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity program for patients with dementia and their caregivers for 3 months, designed by Primary Health Care professionals.
Number of subjects: 134
Study 24684948 — intervention group
Group type: COMPARATOR
Intervention: Regular care (Control group).
Number of subjects: 134
Study 21523325 — intervention group
Group type: EXPERIMENTAL
Intervention: Unidirectional barbed Glycolic acid‐trimethylene carbonate (group 2)
Number of subjects: 55
Study 21523325 — intervention group
Group type: COMPARATOR
Intervention: Monofilament Polyglecaprone‐25 (group 1)
Number of subjects: 55
Study 21239366 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-delivered ORLA
Number of subjects: 25
Study 21239366 — intervention group
Group type: COMPARATOR
Intervention: SLP-delivered ORLA
Number of subjects: 25
Study 18204476 — intervention group
Group type: EXPERIMENTAL
Intervention: St John's wort
Number of subjects: 21
Study 18204476 — intervention group
Group type: COMPARATOR
Intervention: gliclazide alone
Number of subjects: 21
Study 16055956 — intervention group
Group type: EXPERIMENTAL
Intervention: Raloxifene 60 mg/d
Number of subjects: 165
Study 16055956 — intervention group
Group type: EXPERIMENTAL
Intervention: Alendronate 10 mg/d
Number of subjects: 165
Study 11876700 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole, 20 mg in the morning
Number of subjects: 12
Study 11876700 — intervention group
Group type: EXPERIMENTAL
Intervention: Famotidine, 10 mg at bedtime
Number of subjects: 12
Study 11876700 — intervention group
Group type: EXPERIMENTAL
Intervention: Famotidine, 10 mg at 05.30 h
Number of subjects: 12
Study 11876700 — intervention group
Group type: EXPERIMENTAL
Intervention: Famotidine, 10 mg at bedtime and at 05.30 h
Number of subjects: 12
Study 10469339 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitric oxide releasing cream (mixed with nitrite and ascorbic acid, applied three times daily)
Number of subjects: 12
Study 10469339 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitric oxide releasing cream (high dose)
Number of subjects: 12
Study 10469339 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitric oxide releasing cream (48 h exposure)
Number of subjects: 12
Study 10469339 — intervention group
Group type: COMPARATOR
Intervention: Ascorbic acid alone (control)
Number of subjects: 12
Study 7562391 — intervention group
Group type: EXPERIMENTAL
Intervention: African American youth
Number of subjects: 0
Study 7562391 — intervention group
Group type: COMPARATOR
Intervention: White American youth
Number of subjects: 0
Study 2186579 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril (Cp)
Number of subjects: 50
Study 2186579 — intervention group
Group type: COMPARATOR
Intervention: Nifedipine (N) or Isosorbide dinitrate (S)
Number of subjects: 50
Study 2186579 — intervention group
Group type: COMPARATOR
Intervention: Digoxin (Dx) and Furosemide (F)
Number of subjects: 50
Study 37747 — intervention group
Group type: EXPERIMENTAL
Intervention: Dihydrotachysterol (DHT) given orally
Number of subjects: 8
Study 37747 — intervention group
Group type: COMPARATOR
Intervention: Synthetic salmon calcitonin (SCT)
Number of subjects: 8
Study 30477032 — intervention group
Group type: EXPERIMENTAL
Intervention: Suture closure
Number of subjects: 350
Study 30477032 — intervention group
Group type: COMPARATOR
Intervention: Staple closure
Number of subjects: 350
Study 28454583 — intervention group
Group type: EXPERIMENTAL
Intervention: PRO feedback
Number of subjects: 0
Study 28454583 — intervention group
Group type: EXPERIMENTAL
Intervention: PRO feedback and Living with lymphoma intervention
Number of subjects: 0
Study 28454583 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 0
Study 26149165 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive video intervention based on behavioral decision research
Number of subjects: 0
Study 26149165 — intervention group
Group type: EXPERIMENTAL
Intervention: Revised interactive video intervention
Number of subjects: 0
Study 23816662 — intervention group
Group type: EXPERIMENTAL
Intervention: Phonological self-cued retrieval strategy
Number of subjects: 19
Study 23816662 — intervention group
Group type: EXPERIMENTAL
Intervention: Semantic self-cued retrieval strategy
Number of subjects: 19
Study 21551506 — intervention group
Group type: EXPERIMENTAL
Intervention: Licofelone
Number of subjects: 161
Study 21551506 — intervention group
Group type: COMPARATOR
Intervention: Naproxen
Number of subjects: 161
Study 21551506 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline score of bone marrow lesions (BML) in the medial compartment
Number of subjects: 161
Study 21551506 — intervention group
Group type: EXPERIMENTAL
Intervention: Medial joint space width (JSW) as assessed by standardised radiographs
Number of subjects: 161
Study 21551506 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of severe medial meniscal tear
Number of subjects: 161
Study 21551506 — intervention group
Group type: EXPERIMENTAL
Intervention: Medial meniscal extrusion
Number of subjects: 161
Study 21551506 — intervention group
Group type: EXPERIMENTAL
Intervention: C-reactive protein level
Number of subjects: 161
Study 21551506 — intervention group
Group type: EXPERIMENTAL
Intervention: Change in cartilage volume of the medial compartment
Number of subjects: 161
Study 21551506 — intervention group
Group type: EXPERIMENTAL
Intervention: Change in cartilage volume of the global knee
Number of subjects: 161
Study 21551506 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduction in the JSW of greater than 7%
Number of subjects: 161
Study 21551506 — intervention group
Group type: EXPERIMENTAL
Intervention: WOMAC pain scores
Number of subjects: 161
Study 21551506 — intervention group
Group type: EXPERIMENTAL
Intervention: WOMAC function scores
Number of subjects: 161
Study 21551506 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline severe medial meniscal tear
Number of subjects: 161
Study 21551506 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of medial BML
Number of subjects: 161
Study 18808275 — intervention group
Group type: EXPERIMENTAL
Intervention: Credit card presence
Number of subjects: 0
Study 18808275 — intervention group
Group type: EXPERIMENTAL
Intervention: Decomposition strategy
Number of subjects: 0
Study 18808275 — intervention group
Group type: EXPERIMENTAL
Intervention: Scrip (stored value certificate)
Number of subjects: 0
Study 18808275 — intervention group
Group type: COMPARATOR
Intervention: Cash and gift certificates
Number of subjects: 0
Study 17164314 — intervention group
Group type: EXPERIMENTAL
Intervention: PTH(1-84) therapy alone
Number of subjects: 178
Study 17164314 — intervention group
Group type: EXPERIMENTAL
Intervention: PTH(1-84) therapy with alendronate
Number of subjects: 178
Study 17164314 — intervention group
Group type: EXPERIMENTAL
Intervention: PTH(1-84) therapy
Number of subjects: 178
Study 17164314 — intervention group
Group type: EXPERIMENTAL
Intervention: Defined algorithm for managing hypercalcemia
Number of subjects: 178
Study 15088780 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal administration of laboratory passaged wild-type influenza viruses
Number of subjects: 0
Study 15088780 — intervention group
Group type: EXPERIMENTAL
Intervention: Attenuated viruses inoculation in children
Number of subjects: 0
Study 15088780 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum antibody
Number of subjects: 0
Study 15088780 — intervention group
Group type: EXPERIMENTAL
Intervention: Protective factors in adults with lower levels of HI antibody
Number of subjects: 0
Study 15088780 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaccination
Number of subjects: 0
Study 15088780 — intervention group
Group type: EXPERIMENTAL
Intervention: Mucosal antibody measurement
Number of subjects: 0
Study 11938829 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Taohong Siwu Decoction (MTSD)
Number of subjects: 95
Study 11938829 — intervention group
Group type: COMPARATOR
Intervention: Heparin (Control)
Number of subjects: 95
Study 9172023 — intervention group
Group type: EXPERIMENTAL
Intervention: Ohmeda 3740 (ear probe)
Number of subjects: 8
Study 9172023 — intervention group
Group type: EXPERIMENTAL
Intervention: Nellcor N200 reflectance oximeter
Number of subjects: 8
Study 9172023 — intervention group
Group type: EXPERIMENTAL
Intervention: Novametrix Oxypleth
Number of subjects: 8
Study 1400915 — intervention group
Group type: EXPERIMENTAL
Intervention: Early computed tomography (CT) findings
Number of subjects: 53
Study 1400915 — intervention group
Group type: EXPERIMENTAL
Intervention: Late computed tomography (CT) findings
Number of subjects: 53
Study 1400915 — intervention group
Group type: EXPERIMENTAL
Intervention: Parenchymal lesions in the right hemisphere
Number of subjects: 53
Study 1400915 — intervention group
Group type: EXPERIMENTAL
Intervention: Parenchymal lesions in the left hemisphere
Number of subjects: 53
Study 3890805 — intervention group
Group type: EXPERIMENTAL
Intervention: Biobrane
Number of subjects: 31
Study 3890805 — intervention group
Group type: COMPARATOR
Intervention: Scarlet Red
Number of subjects: 31
Study 30398646 — intervention group
Group type: EXPERIMENTAL
Intervention: Quercetin 3-glucoside (160 mg/d)
Number of subjects: 37
Study 30398646 — intervention group
Group type: EXPERIMENTAL
Intervention: (−)-Epicatechin (100 mg/d)
Number of subjects: 37
Study 30398646 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study 27234606 — intervention group
Group type: EXPERIMENTAL
Intervention: Bipolar radiofrequency thermocoagulation
Number of subjects: 168
Study 27234606 — intervention group
Group type: COMPARATOR
Intervention: Monopolar radiofrequency thermocoagulation (control group)
Number of subjects: 168
Study 24388057 — intervention group
Group type: EXPERIMENTAL
Intervention: Biofeedback cycling training (30 minutes/time, 5 times per week for 4 weeks)
Number of subjects: 31
Study 24388057 — intervention group
Group type: EXPERIMENTAL
Intervention: Biofeedback cycling training
Number of subjects: 31
Study 24388057 — intervention group
Group type: COMPARATOR
Intervention: Conventional rehabilitation
Number of subjects: 31
Study 21732500 — intervention group
Group type: EXPERIMENTAL
Intervention: Family workshops with educational and skills-based components
Number of subjects: 48
Study 21732500 — intervention group
Group type: COMPARATOR
Intervention: Individual family work
Number of subjects: 48
Study 20447925 — intervention group
Group type: EXPERIMENTAL
Intervention: Milk consumption during adulthood
Number of subjects: 0
Study 20447925 — intervention group
Group type: COMPARATOR
Intervention: Lactase persistence genotype at rs4988235 among controls
Number of subjects: 0
Study 20447925 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactase persistence genotype at rs4988235 in RCC patients
Number of subjects: 0
Study 18949902 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined cervical plexus block
Number of subjects: 324
Study 18949902 — intervention group
Group type: COMPARATOR
Intervention: Superficial cervical plexus block
Number of subjects: 324
Study 15763304 — intervention group
Group type: EXPERIMENTAL
Intervention: Henschke shielded applicator
Number of subjects: 20
Study 15763304 — intervention group
Group type: COMPARATOR
Intervention: Fletcher-Suit-Declos applicator
Number of subjects: 20
Study 12509211 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure to Mozart's Sonata K.448 (Mozart effect)
Number of subjects: 40
Study 12509211 — intervention group
Group type: COMPARATOR
Intervention: Musicians
Number of subjects: 40
Study 12509211 — intervention group
Group type: COMPARATOR
Intervention: Years spent in music training
Number of subjects: 40
Study 10848143 — intervention group
Group type: EXPERIMENTAL
Intervention: active cognitive stimulation
Number of subjects: 87
Study 10848143 — intervention group
Group type: EXPERIMENTAL
Intervention: passive stimulation
Number of subjects: 87
Study 10848143 — intervention group
Group type: COMPARATOR
Intervention: control
Number of subjects: 87
Study 8753943 — intervention group
Group type: EXPERIMENTAL
Intervention: Clear go signals
Number of subjects: 24
Study 8753943 — intervention group
Group type: EXPERIMENTAL
Intervention: Ambiguous go signals
Number of subjects: 24
Study 8753943 — intervention group
Group type: EXPERIMENTAL
Intervention: No-go signals
Number of subjects: 24
Study 8753943 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 24
Study 1834099 — intervention group
Group type: EXPERIMENTAL
Intervention: Sufentanil 20 micrograms added to 0.5% bupivacaine and epinephrine (1:200,000)
Number of subjects: 60
Study 1834099 — intervention group
Group type: EXPERIMENTAL
Intervention: Sufentanil 30 micrograms added to 0.5% bupivacaine and epinephrine (1:200,000)
Number of subjects: 60
Study 1834099 — intervention group
Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 60
Study 7124311 — intervention group
Group type: COMPARATOR
Intervention: Halothane anaesthesia
Number of subjects: 32
Study 7124311 — intervention group
Group type: EXPERIMENTAL
Intervention: Neurolept anaesthesia
Number of subjects: 32
Study 27377563 — intervention group
Group type: EXPERIMENTAL
Intervention: Stress management skills
Number of subjects: 253
Study 27377563 — intervention group
Group type: EXPERIMENTAL
Intervention: Fight avoidance skills
Number of subjects: 253
Study 27377563 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotional distress
Number of subjects: 253
Study 27377563 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-esteem
Number of subjects: 253
Study 27377563 — intervention group
Group type: EXPERIMENTAL
Intervention: Stress management skills and fight avoidance skills (combined)
Number of subjects: 253
Study 28743816 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher levels of penile anaerobes in uncircumcised men who became infected with HIV during the trial.
Number of subjects: 0
Study 28743816 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased abundances of anaerobic bacteria.
Number of subjects: 0
Study 28743816 — intervention group
Group type: EXPERIMENTAL
Intervention: Penile anaerobes as a risk factor for HIV.
Number of subjects: 0
Study 28743816 — intervention group
Group type: EXPERIMENTAL
Intervention: Penile anaerobes shared between heterosexual partners.
Number of subjects: 0
Study 26729441 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermediate Risk with Good Response (IR-GR) - 4 cycles of platinum and etoposide (PE)
Number of subjects: 579
Study 26729441 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermediate Risk with Partial Response (IR-PR) - 3 cycles of PE plus 3 cycles of ifosfamide, vinblastine, and bleomycin
Number of subjects: 579
Study 26729441 — intervention group
Group type: EXPERIMENTAL
Intervention: High Risk with Good Response (HR-GR) - 4 cycles of PE and ifosfamide (PEI)
Number of subjects: 579
Study 26729441 — intervention group
Group type: EXPERIMENTAL
Intervention: High Risk with Partial Response (HR-PR) - 6 cycles of PEI
Number of subjects: 579
Study 24433317 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous wound infusion of a local anaesthetic
Number of subjects: 60
Study 24433317 — intervention group
Group type: COMPARATOR
Intervention: Standard intravenous piritramide
Number of subjects: 60